Surge in respiratory illnesses reported in China

Chinese authorities from the National Health Commission have reported an increase in incidence of respiratory diseases in China.

‘We dodged a bullet’: Biotech and pharma react to selection of Marty Makary for FDA commissioner

STAT reporters reached out to key figures in biotech, pharma, and medical devices to find out what they think about President-elect Trump’s pick of Johns

November 23, 2024

Roche’s PI3K inhibitor wins FDA priority review for breast cancer

Inavolisib is an oral PI3 kinase (PI3K) inhibitor that dysregulates PI3K signalling in the PI3K/Akt/mTOR pathway, which regulates cell growth and survival. Image Credit: Sundry

May 29, 2024

USC-led team develops vaccine to boost immune system against superbugs

What if a vaccine, given to patients just before or after arriving at the hospital, could protect them against lethal superbugs that lurk in healthcare

October 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.